S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes

Cell Calcium - Tập 41 - Trang 135-143 - 2007
Mirko Völkers1, Christopher M. Loughrey2, Niall MacQuaide2, Andrew Remppis1, Brent R. DeGeorge3, Frederic v. Wegner4, Oliver Friedrich4, Rainer H.A. Fink4, Walter J. Koch3, Godfrey L. Smith2, Patrick Most1,3
1Department of Internal Medicine III, Laboratory for Cardiac Stem Cell and Gene Therapy, Division of Cardiology, INF 350, University of Heidelberg, 69120 Heidelberg, Germany
2Institute of Biomedical Life Sciences, University of Glasgow, Glasgow G128Q, UK
3Center for Translational Medicine, George Zallie & Family Laboratory for Cardiovascular Gene Therapy, Department of Medicine, Thomas Jefferson University, 19107 Philadelphia, PA, USA
4Institute of Physiology and Pathophysiology, Medical Biophysics, INF 326, University of Heidelberg, 69120 Heidelberg, Germany

Tài liệu tham khảo

Haimoto, 1988, S100a0 (alpha alpha) protein in cardiac muscle. Isolation from human cardiac muscle and ultrastructural localization, Eur. J. Biochem., 171, 409, 10.1111/j.1432-1033.1988.tb13805.x Kato, 1985, S100ao (alpha alpha) protein is mainly located in the heart and striated muscles, Biochim. Biophys. Acta, 842, 146, 10.1016/0304-4165(85)90196-5 Kiewitz, 2000, Transcriptional regulation of S100A1 and expression during mouse heart development, Biochim. Biophys. Acta, 1498, 207, 10.1016/S0167-4889(00)00097-5 Kettlewell, 2005, S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes, J. Mol. Cell. Cardiol., 39, 900, 10.1016/j.yjmcc.2005.06.018 Most, 2005, Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes, J. Cell Sci., 118, 421, 10.1242/jcs.01614 Most, 2004, Cardiac adenoviral S100A1 gene transfer rescues failing myocardium, J. Clin. Invest., 114, 1550, 10.1172/JCI21454 Most, 2003, Transgenic overexpression of the Ca2+ binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance, J. Biol. Chem., 278, 33809, 10.1074/jbc.M301788200 Treves, 1997, Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle, Biochemistry, 36, 11496, 10.1021/bi970160w Fano, 1989, S-100a0 protein stimulates Ca2+-induced Ca2+ release from isolated sarcoplasmic reticulum vesicles, FEBS Lett., 255, 381, 10.1016/0014-5793(89)81127-5 Most, 2003, The C-terminus (aa 75–94) and the linker region (aa 42–54) of the Ca2+ binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibres, J. Biol. Chem., 278, 26356, 10.1074/jbc.M303338200 Most, 2003, Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular-regulated kinase (ERK1/2) pathway, J. Biol. Chem., 278, 48404, 10.1074/jbc.M308587200 Remppis, 2002, The small EF-hand Ca2+ binding protein S100A1 increases contractility and Ca2+ cycling in rat cardiac myocytes, Basic. Res. Cardiol., 97, 10.1007/s003950200031 Loughrey, 2004, Overexpression of FK506-binding protein FKPB12.6 alters excitation–contraction coupling in adult rabbit cardiomyocytes., J. Physiol., 556, 919, 10.1113/jphysiol.2003.057166 Cheng, 1999, Amplitude distribution of calcium sparks in confocal images: theory and studies with an automatic detection method, Biophys. J., 76, 606, 10.1016/S0006-3495(99)77229-2 Wehrens, 2003, FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death, Cell, 113, 829, 10.1016/S0092-8674(03)00434-3 Groves, 1998, A model for target protein binding to calcium-activated S100 dimers, FEBS Lett., 421, 175, 10.1016/S0014-5793(97)01535-4 Osterloh, 1998, Hydrophobic residues in the C-terminal region of S100A1 are essential for target protein binding but not for dimerization, Cell Calcium, 24, 137, 10.1016/S0143-4160(98)90081-1 Wang, 2001, Preliminary X-ray crystallographic analysis of a Ca2+-binding protein human S100A1, Acta Crystallogr. D. Biol. Crystallogr., 57, 882, 10.1107/S0907444901005273 Wright, 2005, The three-dimensional solution structure of Ca2+-bound S100A1 as determined by NMR Spectroscopy, J. Mol. Biol., 353, 410, 10.1016/j.jmb.2005.08.027 Zimmer, 2003, Molecular mechanisms of S100-target protein interactions, Microsc. Res. Tech., 60, 552, 10.1002/jemt.10297 Diaz, 2005, The control of sarcoplasmic reticulum Ca content in cardiac muscle, Cell Calcium, 38, 391, 10.1016/j.ceca.2005.06.017 Hamilton, 2005, Ryanodine receptors, Cell Calcium, 38, 253, 10.1016/j.ceca.2005.06.037 Wehrens, 2004, Molecular determinants of altered contractility in heart failure, Ann. Med., 36, 70, 10.1080/17431380410032481 Bers, 2004, Macromolecular complexes regulating cardiac ryanodine receptor function, J. Mol. Cell Cardiol., 37, 417, 10.1016/j.yjmcc.2004.05.026 Valdivia, 1998, Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors, Trends Pharmacol. Sci., 19, 479, 10.1016/S0165-6147(98)01269-3 Baudier, 1986, Ions binding to S100 proteins. II. Conformational studies and calcium-induced conformational changes in S100 alpha alpha protein: the effect of acidic pH and calcium incubation on subunit exchange in S100a (alpha beta) protein, J. Biol. Chem., 261, 8204, 10.1016/S0021-9258(19)83896-6 Baudier, 1986, Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein, J. Biol. Chem., 261, 8192, 10.1016/S0021-9258(19)83895-4 Heizmann, 1998, New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family, Biometals, 11, 383, 10.1023/A:1009212521172 Most, 2001, S100A1: a regulator of myocardial contractility, Proc. Natl. Acad. Sci. U.S.A., 98, 13889, 10.1073/pnas.241393598 Okada, 2004, S100A1 is a novel molecular chaperone and a member of the Hsp70/Hsp90 multichaperone complex, J. Biol. Chem., 279, 4221, 10.1074/jbc.M309014200 Pleger, 2005, S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction, Mol. Ther., 12, 1120, 10.1016/j.ymthe.2005.08.002 Remppis, 1996, Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy, Biochim. Biophys. Acta, 1313, 253, 10.1016/0167-4889(96)00097-3 Most, 2003, Sealing the leak, healing the heart, Nat. Med., 9, 993, 10.1038/nm0803-993 P. Most, H. Seiffert, E.G. Gao, H. Funakoshi, M. Völkers, J. Heierhorst, A. Remppis, S.T. Pleger, B. DeGeorge, A.D. Eckhart, A.M. Feldman, W.J. Koch, Cardiac S100A1 protein levels determine contractile performance and propensity towards heart failure after myocardial infarction, Circulation, 2006, in press.